ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO282

Mice With a Genomic Deletion of Pkhd1 Exons 3-67 Have Minimal Renal Manifestations but Evidence of Transcriptional Network Changes by snRNA Sequencing

Session Information

Category: Genetic Diseases of the Kidneys

  • 1101 Genetic Diseases of the Kidneys: Cystic

Authors

  • Ishimoto, Yu, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States
  • Menezes, Luis F., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States
  • Zhou, Fang, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States
  • Yoshida, Teruhiko, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States
  • Outeda, Patricia, University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Watnick, Terry J., University of Maryland School of Medicine, Baltimore, Maryland, United States
  • Germino, Gregory G., National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, United States
Background

Autosomal recessive polycystic kidney disease (ARPKD) is caused mostly by mutations in PKHD1. We previously generated a mouse with a genomic deletion of exons 3-67 of murine Pkhd1. While Pkhd1del3-67/del3-67 kidneys are somewhat enlarged and show no obvious morphological or histological changes. We and others have previously reported kidney cysts in ARPKD models, suggesting that compensatory pathways might prevent cystogenesis. We therefore investigated transcriptomic changes in Pkhd1del3-67/del3-67 kidneys and controls, using single-nuclei RNA-sequencing (snRNAseq).

Methods

We sampled kidneys from three male 4-weeks old Pkhd1del3-67/del3-67 and three littermate controls. After quality control filtering, we analyzed a total of 83,322 cells, with a median number of ~ 4000 transcripts/cell.

Results

Clusters of cells representing most nephron epithelial cell types had Pkhd1 expression. Grouping similar cell types and re-clustering, we observed no differences between mutant and control samples. Within each cell type, multiple genes distributed across the genome had significant p-value changes but most had minimal fold-change differences, and we found no evidence of significantly dysregulated pathways by gene-set enrichment analysis. Using network analysis, we inferred transcriptional networks and scored genes based on their connectivity. We found evidence that a few pathways were significantly changed in different nephron segments, including some with transcriptional regulator activity. To investigate consistent changes in all nephron segments, we derived a consensus network including only gene-gene interactions present in all segments. Within this network, we identified genes with multiple connections (hubs) that were differentially expressed and showed changed in connectivity between mutants and controls, suggestive of re-wiring. Pathway enrichment analysis of likely re-wired differentially expressed hubs identified ubiquitin-conjugation as a major change in Pkhd1 mutants, consistent with previous results.

Conclusion

Pkhd1del3-67/del3-67 kidneys showed no obvious morphological changes or compensatory transcriptional profiles. Network analyses, however, identified possible re-wiring of ubiquitin-conjugation pathway.

Funding

  • NIDDK Support